Diabetes induction and pancreatic transplantation in the cynomolgus monkey: methodological considerations

The aim of this study was to develop a model for pancreatic transplantation in the primate in order to test a new immunosuppressive drug. Initially, streptozotocin was used to induce insulin-dependent diabetes mellitus, but it was found to be ineffective and associated with a high morbidity. Furthermore, streptozotocin-induced insulin-dependent diabetes mellitus did not always persist, thus invalidating the evaluation of pancreatic graft function. Therefore, total pancreatectomy was introduced and combined with the pancreatic allotransplantation as a single procedure. Enteric diversion of the pancreatic juice was chosen since this avoids exocrine pancreatic insufficiency and facilitates the oral administration of the test drug. Intra-arterial monitoring of blood pressure and blood gases during the operation and avoidance of hypothermia in the animal were found to be the most improtant factors contributing to a successful outcome from the operative procedure.

[1]  G. Hard.  Identification of a high-frequency model for renal carcinoma by the induction of renal tumors in the mouse with a single dose of streptozotocin. , 1985, Cancer research.

[2]  M. Stegall,et al.  Pancreatic islet transplantation in cynomolgus monkeys. Initial studies and evidence that cyclosporine impairs glucose tolerance in normal monkeys. , 1989, Transplantation.

[3]  J. Gillman,et al.  The relationship of hyperglycaemia to hyperlipaemia and ketonaemia in depancreatized baboons (Papio ursinus). , 1958, The Journal of endocrinology.

[4]  S. Wolfe‐Coote,et al.  Prolongation of intraperitoneal segmental pancreatic allografts in primates receiving cyclosporin A. , 1984, Surgery.

[5]  L. Orci,et al.  Studies of the Diabetogenic Action of Streptozotocin.∗ , 1967, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[6]  Pitkin Rm,et al.  Diabetogenic Effects of Streptozotocin in Rhesus Monkeys , 1970 .

[7]  S. Wolfe‐Coote,et al.  Intraperitoneal transplantation of vascularized segmental pancreatic autografts without duct ligation in the primate. , 1983, Surgery.

[8]  M. Henry,et al.  Toxicologic evaluation of streptozotocin (NSC 85998) in mice, dogs and monkeys. , 1980, Drug and chemical toxicology.

[9]  A. Renold,et al.  Diabetogenic action of streptozotocin: relationship of dose to metabolic response. , 1969, The Journal of clinical investigation.

[10]  N. Bansal,et al.  Frequency and size of atherosclerotic plaques in vasectomized diabetic monkeys. , 1986, International journal of fertility.

[11]  O. Jonasson,et al.  The pathophysiology of experimental insulin-deficient diabetes in the monkey. Implications for pancreatic transplantation. , 1985, Annals of surgery.

[12]  M. Glitzer,et al.  Light and Electron Microscopy of Lesions in Rats Rendered Diabetic with Streptozotocin , 1967, Diabetes.

[13]  G. Hoganson,et al.  Streptozotocin Diabetes in the Monkey: Plasma Levels of Glucose, Insulin, Glucagon, and Somatostatin, with Corresponding Morphometric Analysis of Islet Endocrine Cells , 1980, Diabetes.

[14]  O. Jonasson,et al.  Peripheral glomerular basement membrane thickness in the normal and diabetic monkey. , 1984, Laboratory investigation; a journal of technical methods and pathology.

[15]  J. Widness,et al.  Hemoglobin AIc in the Glucose-intolerant, Streptozotocin-treated or Pancreatectomized Macaque Monkey , 1978, Diabetes.

[16]  O. Jonasson,et al.  Biochemical changes in rhesus monkey during the first days after streptozotocin administration are indicative of selective beta cell destruction. , 1988, Metabolism: clinical and experimental.